Hydrocarbon autoxidation, a free radical chain reaction, is one of the most important chemical processes, and is ubiquitous in biological systems and industry. While it is vital to maintaining cellular homeostasis and plays central roles in the immune and inflammatory responses, it is also believed to play a role in the onset and development of diseases and degenerative disorders when not kept in check. In vivo, this process is generally initiated by the reduction of O2 to superoxide (O2•-), which can then afford various reactive oxygen species (ROS), such as HOO•, H2O2, HO•, and 1O2. Recently, it was suggested that antibodies, as part of the immune system, produce another ROS: ozone. The evidence for endogenous ozone formation was based largely on the isolation of the known cholesterol ozonolysis products in extracts of arterial plaque and brain tissue. Identification was accomplished by derivatization and subsequent HPLC-MS analysis. Herein, an alternative, more likely explanation for the appearance of these two compounds and their derivatized forms is given, via acid-catalyzed Hock cleavage of cholesterol 5-hydroperoxide. Radical-trapping chain-breaking antioxidants inhibit hydrocarbon autoxidation; in Nature and as additives in industrial materials, formulations, etc. Nature typically employs phenols in this context, and it is well documented that their potency is based largely on the lability of their phenolic O-H bond. While their reactivity can be improved by making the phenol more electron-rich by introducing electron-donating groups on the aromatic ring, this increases their air (oxygen) sensitivity, leading them to decompose in air and generate ROS themselves! To prevent this, nitrogen(s) can be introduced in the aromatic ring to make 3-pyridinols and 5-pyrimidinols; the most effective air-stable radical-trapping antioxidants reported to date. Unfortunately, introduction of nitrogen in the phenolic ring leads to a concomitant increase in the acidity of the O-H bond, leading to stronger interactions with H-bond accepting solvents. This interaction reduces the efficacy of these compounds as antioxidants in polar and heterogeneous media. Herein we describe our efforts to minimize the effect of this interaction, thereby maintaining the strong antioxidant activities of 3-pyridinols and 5-pyrimidinols, by introducing two tert-butyl moieties flanking the reactive hydroxyl group. / Thesis (Master, Chemistry) -- Queen's University, 2008-11-21 14:30:19.24

abstract: Cellular redox phenomena are essential for the life of organisms. Described here is a summary of the synthesis of a number of redox-cycling therapeutic agents. The work centers on the synthesis of antitumor antibiotic bleomycin congeners. In addition, the synthesis of pyridinol analogues of alpha-tocopherol is also described. The bleomycins (BLMs) are a group of glycopeptide antibiotics that have been used clinically to treat several types of cancers. The antitumor activity of BLM is thought to be related to its degradation of DNA, and possibly RNA. Previous studies have indicated that the methylvalerate subunit of bleomycin plays an important role in facilitating DNA cleavage by bleomycin and deglycobleomycin. A series of methylvalerate analogues have been synthesized and incorporated into deglycobleomycin congeners by the use of solid-phase synthesis. All of the deglycobleomycin analogues were found to effect the relaxation of plasmid DNA. Those analogues having aromatic C4-substituents exhibited cleavage efficiency comparable to that of deglycoBLM A5. Some, but not all, of the deglycoBLM analogues were also capable of mediating sequence-selective DNA cleavage. The second project focused on the synthesis of bicyclic pyridinol analogues of alpha-tocopherol. Bicyclic pyridinol antioxidants have recently been reported to suppress the autoxidation of methyl linoleate more effectively than alpha-tocopherol. However, the complexity of the synthetic routes has hampered their further development as therapeutic agents. Described herein is a concise synthesis of two bicyclic pridinol antioxidants and a facile approach to their derivatives with simple alkyl chains attached to the antioxidant core. These analogues were shown to retain biological activity and exhibit tocopherol-like behaviour. / Dissertation/Thesis / Ph.D. Chemistry 2011

Chapter 2 In solution, py(mi)ridinols 1.33, 1.34 and 1.35 are 2-, 5- and 28-fold more reactive antioxidants, respectively, than α-TOH (the most potent lipid-soluble antioxidant in nature). In order to develop a highly-reactive fluorescent indicator of lipid peroxidation in cells, we sought to couple these antioxidants with boron-dipyrro- methene (BODIPY) dyes, such that the resulting conjugates will display a significant fluorecence enhancement upon oxidation. This chapter details efforts towards the synthesis of these compounds. Chapter 3 Lipoxygenases are a family of important enzymes that catalyze the dioxygenation of arachidonic acid to yield a variety of potent lipid mediators that have been implicated in the pathogenesis of numerous degenerative conditions. We have undertaken a preliminary study of the effect of replacing the unsaturation in the related polyunsaturated lipid linoleic acid with cyclopropane rings on both the oxidizability of the lipid, as well as lipoxygenase’s ability to utilize it as a substrate. We anticipate that these analogs will be useful in co-crystallization studies with the enzyme that will provide unique insight into substrate acquisition, binding and the necessary conformation for catalysis. / Thesis (Master, Chemistry) -- Queen's University, 2011-11-10 16:15:05.643

Exposure to halogenated phenols and pyridinols is of increasing concern because of their wide use and distribution. This research was initiated to determine the distribution, accumulation, and depletion of a group of halogenated phenols and a pyridinol in selected tissues of male weanling rats at different time intervals following a single oral dose of 0.33 or 1.66 m moles per kg body weight. The halogenated phenols and pyridinol were distributed differently in every tissue sampled following their administration, even though the amount administered was the same in each case. The concentrations in tissue were found in the order: 2,4,5-trichloro-phenol > 4-bromo-2,5-dichlorophenol > 4-iodo-2,5-dichlorophenol > 3,5,6-trichloro-2-pyridonol in kidney and fat, whereas the series 3,5,6-trichloro-2-pyridinol > 4-iodo-2,5-dichlorophenol > 4-bromo-2,5-dichlorophenol > 3,5,6-trichlorophenol occurred in liver. No structurally significant series was observed for their concentrations in blood. All halogenated phenols and pyridinol concentrations in tissues declined rapidly with time but not always in an apparently log linear fashion. Rates were greatest for clearance from blood. The highest concentration of halogenated phenols was in kidney among the tissues studied, whereas the highest concentration of halogenated pyridinol was in liver. Relationships were found between the relative lipophilicity, as indicated by the chromatographic Rm value, and the concentrations of these compounds in tissues. The RH (i.e., relative lipophilicity) was generally very well correlated with the log concentration of compounds in tissues observed 24 h after dosing. The correlation coefficients ranged between .517 and .995 among tissues. Correlations were positive between the Rm values and 24 h concentrations in adipose tissue, and kidney, but negative for the relationship between the Rm and 24 h concentrations in blood and liver.